Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT01423032 · COMPLETED
Trial details
- NCT number
- NCT01423032
- Sponsor
- WiSP Wissenschaftlicher Service Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2009-05-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.